Antipyretic Activity

Living reference work entry

Abstract

Treatment with antipyretics has been very important in the pre-antibiotic era. Nevertheless, for treatment of acute viral diseases and for treatment of protozoal infections like malaria, the reduction of elevated body temperature by antipyretics is still necessary. For anti-inflammatory compounds, an antipyretic activity is regarded as a positive side effect. To evaluate these properties, fever is induced in rabbits or rats by injection of lipopolysaccharides or brewer’s yeast.

Keywords

Antipyretic Effect Elevated Body Temperature Antipyretic Drug Organum Vasculosum Lamina Terminalis Record Body Temperature 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

References and Further Reading

General Considerations

  1. Bejanian M, Jones BL, Syapin PJ, Finn DA, Alkana RJ (1991) Brain temperature and ethanol sensitivity in C57 mice: a radiotelemetric study. Pharmacol Biochem Behav 39:457–463CrossRefPubMedGoogle Scholar
  2. Brune K, Alpermann H (1983) Non-acidic pyrazoles: inhibition of prostaglandin production, carrageenan oedema and yeast fever. Agents Actions 13:360–363CrossRefPubMedGoogle Scholar
  3. Burn JH, Finney DJ, Goodwin LG (1950) Chapter XIV: antipyretics and analgesics. In: Biological standardisation. Oxford University Press, London/New York, pp 312–319Google Scholar
  4. Clement JG, Mills P, Brockway B (1989) Use of telemetry to record body temperature and activity in mice. J Pharmacol Methods 21:129–140CrossRefPubMedGoogle Scholar
  5. Gallaher EJ, Egner DA, Swen J (1985) Automated remote temperature measurement in small animals using a telemetry/microcomputer interface. Comput Biol Med 15:103–110CrossRefPubMedGoogle Scholar
  6. Guillet MC, Molinié B, Laduron PM, Terlain B (1990) Effects of ketoprofen in adjuvant-induced arthritis measured in a new telemetric model test. Eur J Pharmacol 183:2266–2267CrossRefGoogle Scholar
  7. Inoue K, Fujisawa H, Sasaki Y, Nishimura T, Nishimura I, Inoue Y, Yokota M, Masuda T, Ueda F, Shibata Y, Kimura K, Inoue K, Komiya Y, Nishioka J (1991) Pharmacological properties of the new non-steroidal anti-inflammatory agent etodolac. Arzneim Forsch/Drug Res 41:228–235Google Scholar
  8. Kluger MJ, Carole AC, Franklin B, Freter R, Abrams BD (1990) Effect of gastrointestinal flora on body temperature of rats and mice. Am J Physiol 258:R552–R557PubMedGoogle Scholar
  9. Loux JJ, DePalma PD, Yankell SL (1972) Antipyretic testing of aspirin in rats. Toxicol Appl Pharmacol 22:672–675CrossRefPubMedGoogle Scholar
  10. Luheshi G, Miller AJ, Brouwer S, Dascombe MJ, Rothwell NJ, Hopkins SJ (1996) Interleukin-1 receptor antagonist inhibits endotoxin fever and systemic interleukin-6 induction in the rat. Am J Physiol Endocrinol Metab 270/1 33–1:E91–E95Google Scholar
  11. Miller AJ, Hopkins SJ, Luheshi GN (1997) Sites of action of IL-1 in the development of fever and cytokine response to tissue inflammation in the rat. Br J Pharmacol 120:1274–1279CrossRefPubMedCentralPubMedGoogle Scholar
  12. Riley JL, Thursten JR, Egemo CL, Elliot HL (1978) A radiotelemetry transmitter for transmitting temperatures from small animals. J Appl Physiol 45:1016–1018PubMedGoogle Scholar
  13. Roszkowski AP, Rooks WH, Tomolonis AJ, Miller LM (1971) Anti-inflammatory and analgesic properties of d-2-(6′-methoxy-2′-naphthyl)-propionic acid (NAPROXEN). J Pharmacol Exp Ther 179:114–123PubMedGoogle Scholar
  14. Shimada SG, Otterness IG, Stitt JT (1994) A study of the mechanism of action of the mild analgesic dipyrone. Agents Actions 41:188–192Google Scholar
  15. Smith PK, Hambourger WE (1935) The ratio of the toxicity of acetanilide to its antipyretic activity in rats. J Pharmacol Exp Ther 54:346–351Google Scholar
  16. Stitt JT, Shimada SG (1991) Calcium channel blockers inhibit endogenous pyrogen fever in rats and rabbits. J Appl Physiol 71:951–955PubMedGoogle Scholar
  17. Tanaka K, Shimotori T, Makino S, Aikawa Y, Inaba T, Yoshida C, Takano S (1992) Pharmacological studies of the new anti-inflammatory agent 3-formylamino-7-methylsulfonylamino-6-phenoxy-4H-1-benzopyran-4-one. 1st communication: anti-inflammatory, analgesic and other related properties. Arzneim Forsch/Drug Res 42:935–944Google Scholar
  18. Watkinson WP, Highfill JW, Slade R, Hatch GE (1996) Ozone toxicity in the mouse: comparison and modeling of responses in susceptible and resistant strains. J Appl Physiol 80:2134–2142PubMedGoogle Scholar

Antipyretic Testing in Rabbits

  1. Cashin CH, Heading CE (1968) The assay for anti-pyretic drugs in mice, using intracerebral injection of pyretogenins. Br J Pharmacol 34:148–158CrossRefPubMedCentralPubMedGoogle Scholar
  2. Cashin CH, Dawson W, Kitchen EA (1977) The pharmacology of benoxaprofen (2-[4-chlorophenyl]-α-methyl-5-benzoxazole acetic acid), LRCL 3794, a new compound with anti-inflammatory activity apparently unrelated to prostaglandin synthesis. J Pharm Pharmacol 29:330–336CrossRefPubMedGoogle Scholar
  3. Davidson J, Flower RJ, Milton AS, Peers SH, Rotondo D (1991) Antipyretic actions of human recombinant lipocortin-1. Br J Pharmacol 102:7–9CrossRefPubMedCentralPubMedGoogle Scholar
  4. Deeter LB, Martin LW, Lipton JM (1989) Antipyretic effect of central α-MSH summates with that of acetaminophen or ibuprofen. Brain Res Bull 23:573–575CrossRefPubMedGoogle Scholar
  5. Lee TF, Mora F, Myers RD (1985) Effect of intracerebroventricular vasopressin on body temperature and endotoxin fever of macaque monkey. Am J Physiol 248:R674–R678PubMedGoogle Scholar
  6. Loza Garcia MI, Baamonde Arbaiza A, Hidalgo Balsera A, Andres-Trelles F (1993) Potenciación por dipirona (metamizol) magnésica y dipirona sódica de la hipotermia producida por chlorpromazina en rata anestesiada. An Real Acad Farm 59:181–190Google Scholar
  7. Matuszek M, Szreder Z, Korolkiewicz Z (1990) The antipyretic effect of some newer alpha-1 antagonists. Eur J Pharmacol 183:2279–2280CrossRefGoogle Scholar
  8. Petrova L, Nikolova M, Nikolov R, Stefanova D (1978) Dipyrone and acetylsalicylic acid comparative pharmacological research. Antipyretic, anti-inflammatory and analgesic action. In: Ovtcharov R, Pola W (eds) Proceedings dipyrone. Moscow symposium, Schattauer, Stuttgart/New York, pp 99–107Google Scholar
  9. Shimada SG, Otterness IG, Stitt JT (1994) A study of the mechanism of action of the mild analgesic dipyrone. Agents Actions 41:188–192Google Scholar
  10. Szeder Z (1990) Comparison of the effect of prazosin with that of dihydrobenzperidol and nifedipine on thermoregulatory responses produced by pyrogen in rabbits. Gen Pharmacol 21:833–838CrossRefGoogle Scholar
  11. Szreder Z, Korolkiewicz Z (1991) Inhibition of pyrogen Escherichia coli fever with intracerebral administration of prazosin, dihydrobenzperidol and nifedipin in the rabbits. Gen Pharmacol 22:381–388CrossRefPubMedGoogle Scholar
  12. USP 23 (1995) Pyrogen test. The United States Pharmacopeia 23, p 1718Google Scholar
  13. van Miert AS, van Essen JA, Tromp GA (1972) The antipyretic effect of pyrazolone derivates and salicylates on fever induced with leukocytic or bacterial pyrogen. Arch Int Pharmacodyn 197:388–391PubMedGoogle Scholar
  14. van Miert AS, van der Wal-Komproe LE, van Duin CT (1977) Effects of antipyretic agents on fever and ruminal stasis induced by endotoxins in conscious goats. Arch Int Pharmacodyn 225:39–50PubMedGoogle Scholar
  15. Zimecki M, Schnaper HW, Wieczorek Z, Webb DR, Pierce CW (1990) Inhibition of interleukin 1 (IL-1)-elicited leukocytosis and LPS-induced fever by soluble immune response suppressor (SIRS). Immunopharmacology 19:39–46CrossRefPubMedGoogle Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 2014

Authors and Affiliations

  1. 1.Pfizer IncNew JerseyUSA

Personalised recommendations